Annual Interest Expense
$3.16 M
+$625.80 K+24.72%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual interest expense is $3.16 million, with the most recent change of +$625.80 thousand (+24.72%) on September 30, 2024.
- During the last 3 years, OTLK annual interest expense has risen by +$2.22 million (+237.25%).
- OTLK annual interest expense is now -43.88% below its all-time high of $5.63 million, reached on September 30, 2017.
Performance
OTLK Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$0.00
$0.000.00%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly interest expense is $0.00, unchanged on September 1, 2024.
- OTLK quarterly interest expense is now -100.00% below its all-time high of $2.15 million, reached on September 30, 2017.
Performance
OTLK Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$0.00
-$200.00-100.00%
September 1, 2024
Summary
- As of February 7, 2025, OTLK TTM interest expense is $0.00, with the most recent change of -$200.00 (-100.00%) on September 1, 2024.
- OTLK TTM interest expense is now -100.00% below its all-time high of $5.85 million, reached on December 31, 2017.
Performance
OTLK TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
OTLK Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.7% | - | - |
| 3 y3 years | +237.3% | -100.0% | -100.0% |
| 5 y5 years | -8.9% | -100.0% | -100.0% |
OTLK Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +237.3% | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -8.9% | +237.3% | -100.0% | at low | -100.0% | at low |
| alltime | all time | -43.9% | +250.3% | -100.0% | at low | -100.0% | at low |
Outlook Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $3.16 M(+24.7%) | - | - |
| Sep 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2024 | - | $0.00(-100.0%) | $200.00(-60.0%) |
| Sep 2023 | $2.53 M(+70.2%) | $200.00(-33.3%) | $500.00(+66.7%) |
| Jun 2023 | - | $300.00(-99.9%) | $300.00(-100.0%) |
| Sep 2022 | $1.49 M(+58.9%) | - | - |
| Dec 2021 | - | $351.50 K(+30.6%) | $1.13 M(+20.5%) |
| Sep 2021 | $936.10 K(-46.7%) | $269.20 K(+4.8%) | $936.20 K(+36.5%) |
| Jun 2021 | - | $256.90 K(+2.6%) | $686.00 K(-21.4%) |
| Mar 2021 | - | $250.40 K(+56.8%) | $872.70 K(-33.8%) |
| Dec 2020 | - | $159.70 K(+740.5%) | $1.32 M(-24.9%) |
| Sep 2020 | $1.76 M(-49.3%) | $19.00 K(-95.7%) | $1.76 M(-9.8%) |
| Jun 2020 | - | $443.60 K(-36.3%) | $1.95 M(-24.7%) |
| Mar 2020 | - | $696.20 K(+16.5%) | $2.59 M(-12.2%) |
| Dec 2019 | - | $597.70 K(+184.3%) | $2.94 M(-15.1%) |
| Sep 2019 | $3.47 M | $210.20 K(-80.6%) | $3.47 M(-20.5%) |
| Jun 2019 | - | $1.08 M(+2.6%) | $4.36 M(-1.5%) |
| Mar 2019 | - | $1.05 M(-6.0%) | $4.43 M(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | - | $1.12 M(+1.4%) | $4.29 M(+10.4%) |
| Sep 2018 | $3.89 M(-30.8%) | $1.11 M(-3.7%) | $3.89 M(-21.1%) |
| Jun 2018 | - | $1.15 M(+24.6%) | $4.93 M(-10.8%) |
| Mar 2018 | - | $920.90 K(+28.3%) | $5.53 M(-5.5%) |
| Dec 2017 | - | $717.90 K(-66.6%) | $5.85 M(+4.1%) |
| Sep 2017 | $5.63 M(+203.8%) | $2.15 M(+23.0%) | $5.63 M(+37.4%) |
| Jun 2017 | - | $1.75 M(+40.3%) | $4.09 M(+54.6%) |
| Mar 2017 | - | $1.24 M(+154.3%) | $2.65 M(+36.4%) |
| Dec 2016 | - | $489.10 K(-20.5%) | $1.94 M(+4.9%) |
| Sep 2016 | $1.85 M(-19.4%) | $615.50 K(+105.6%) | $1.85 M(-3.3%) |
| Jun 2016 | - | $299.40 K(-44.3%) | $1.92 M(-11.8%) |
| Mar 2016 | - | $537.90 K(+34.8%) | $2.17 M(-7.2%) |
| Dec 2015 | - | $399.00 K(-41.2%) | $2.34 M(+1.8%) |
| Sep 2015 | $2.30 M(+154.9%) | $679.00 K(+22.4%) | $2.30 M(+42.0%) |
| Jun 2015 | - | $554.80 K(-21.4%) | $1.62 M(+52.2%) |
| Mar 2015 | - | $705.90 K(+97.4%) | $1.06 M(+197.4%) |
| Dec 2014 | - | $357.60 K | $357.60 K |
| Sep 2014 | $901.10 K | - | - |
FAQ
- What is Outlook Therapeutics annual interest expense?
- What is the all time high annual interest expense for Outlook Therapeutics?
- What is Outlook Therapeutics annual interest expense year-on-year change?
- What is Outlook Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Outlook Therapeutics?
- What is Outlook Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Outlook Therapeutics?
What is Outlook Therapeutics annual interest expense?
The current annual interest expense of OTLK is $3.16 M
What is the all time high annual interest expense for Outlook Therapeutics?
Outlook Therapeutics all-time high annual interest expense is $5.63 M
What is Outlook Therapeutics annual interest expense year-on-year change?
Over the past year, OTLK annual interest expense has changed by +$625.80 K (+24.72%)
What is Outlook Therapeutics quarterly interest expense?
The current quarterly interest expense of OTLK is $0.00
What is the all time high quarterly interest expense for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly interest expense is $2.15 M
What is Outlook Therapeutics TTM interest expense?
The current TTM interest expense of OTLK is $0.00
What is the all time high TTM interest expense for Outlook Therapeutics?
Outlook Therapeutics all-time high TTM interest expense is $5.85 M